Medical Devices & Consumables

Global Cardiovascular Therapy Market Research Report 2025

The global market for Cardiovascular Therapy was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Cardiovascular Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cardiovascular Therapy.
The Cardiovascular Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cardiovascular Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cardiovascular Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Medtronic
Boston Scientific
Abbott
LivaNova
BIOTRONIK
Segment by Type
Diabetes
Obesity
Others
Segment by Application
Hospital
Clinic
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cardiovascular Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cardiovascular Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Diabetes
1.2.3 Obesity
1.2.4 Others
1.3 Market by Application
1.3.1 Global Cardiovascular Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cardiovascular Therapy Market Perspective (2020-2031)
2.2 Global Cardiovascular Therapy Growth Trends by Region
2.2.1 Global Cardiovascular Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Cardiovascular Therapy Historic Market Size by Region (2020-2025)
2.2.3 Cardiovascular Therapy Forecasted Market Size by Region (2026-2031)
2.3 Cardiovascular Therapy Market Dynamics
2.3.1 Cardiovascular Therapy Industry Trends
2.3.2 Cardiovascular Therapy Market Drivers
2.3.3 Cardiovascular Therapy Market Challenges
2.3.4 Cardiovascular Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cardiovascular Therapy Players by Revenue
3.1.1 Global Top Cardiovascular Therapy Players by Revenue (2020-2025)
3.1.2 Global Cardiovascular Therapy Revenue Market Share by Players (2020-2025)
3.2 Global Cardiovascular Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Cardiovascular Therapy Revenue
3.4 Global Cardiovascular Therapy Market Concentration Ratio
3.4.1 Global Cardiovascular Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cardiovascular Therapy Revenue in 2024
3.5 Global Key Players of Cardiovascular Therapy Head office and Area Served
3.6 Global Key Players of Cardiovascular Therapy, Product and Application
3.7 Global Key Players of Cardiovascular Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cardiovascular Therapy Breakdown Data by Type
4.1 Global Cardiovascular Therapy Historic Market Size by Type (2020-2025)
4.2 Global Cardiovascular Therapy Forecasted Market Size by Type (2026-2031)
5 Cardiovascular Therapy Breakdown Data by Application
5.1 Global Cardiovascular Therapy Historic Market Size by Application (2020-2025)
5.2 Global Cardiovascular Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Cardiovascular Therapy Market Size (2020-2031)
6.2 North America Cardiovascular Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Cardiovascular Therapy Market Size by Country (2020-2025)
6.4 North America Cardiovascular Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cardiovascular Therapy Market Size (2020-2031)
7.2 Europe Cardiovascular Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Cardiovascular Therapy Market Size by Country (2020-2025)
7.4 Europe Cardiovascular Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cardiovascular Therapy Market Size (2020-2031)
8.2 Asia-Pacific Cardiovascular Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Cardiovascular Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific Cardiovascular Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cardiovascular Therapy Market Size (2020-2031)
9.2 Latin America Cardiovascular Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Cardiovascular Therapy Market Size by Country (2020-2025)
9.4 Latin America Cardiovascular Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cardiovascular Therapy Market Size (2020-2031)
10.2 Middle East & Africa Cardiovascular Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Cardiovascular Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa Cardiovascular Therapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Medtronic
11.1.1 Medtronic Company Details
11.1.2 Medtronic Business Overview
11.1.3 Medtronic Cardiovascular Therapy Introduction
11.1.4 Medtronic Revenue in Cardiovascular Therapy Business (2020-2025)
11.1.5 Medtronic Recent Development
11.2 Boston Scientific
11.2.1 Boston Scientific Company Details
11.2.2 Boston Scientific Business Overview
11.2.3 Boston Scientific Cardiovascular Therapy Introduction
11.2.4 Boston Scientific Revenue in Cardiovascular Therapy Business (2020-2025)
11.2.5 Boston Scientific Recent Development
11.3 Abbott
11.3.1 Abbott Company Details
11.3.2 Abbott Business Overview
11.3.3 Abbott Cardiovascular Therapy Introduction
11.3.4 Abbott Revenue in Cardiovascular Therapy Business (2020-2025)
11.3.5 Abbott Recent Development
11.4 LivaNova
11.4.1 LivaNova Company Details
11.4.2 LivaNova Business Overview
11.4.3 LivaNova Cardiovascular Therapy Introduction
11.4.4 LivaNova Revenue in Cardiovascular Therapy Business (2020-2025)
11.4.5 LivaNova Recent Development
11.5 BIOTRONIK
11.5.1 BIOTRONIK Company Details
11.5.2 BIOTRONIK Business Overview
11.5.3 BIOTRONIK Cardiovascular Therapy Introduction
11.5.4 BIOTRONIK Revenue in Cardiovascular Therapy Business (2020-2025)
11.5.5 BIOTRONIK Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Cardiovascular Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Diabetes
Table 3. Key Players of Obesity
Table 4. Key Players of Others
Table 5. Global Cardiovascular Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Cardiovascular Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Cardiovascular Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Cardiovascular Therapy Market Share by Region (2020-2025)
Table 9. Global Cardiovascular Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Cardiovascular Therapy Market Share by Region (2026-2031)
Table 11. Cardiovascular Therapy Market Trends
Table 12. Cardiovascular Therapy Market Drivers
Table 13. Cardiovascular Therapy Market Challenges
Table 14. Cardiovascular Therapy Market Restraints
Table 15. Global Cardiovascular Therapy Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Cardiovascular Therapy Market Share by Players (2020-2025)
Table 17. Global Top Cardiovascular Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cardiovascular Therapy as of 2024)
Table 18. Ranking of Global Top Cardiovascular Therapy Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Cardiovascular Therapy Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Cardiovascular Therapy, Headquarters and Area Served
Table 21. Global Key Players of Cardiovascular Therapy, Product and Application
Table 22. Global Key Players of Cardiovascular Therapy, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Cardiovascular Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Cardiovascular Therapy Revenue Market Share by Type (2020-2025)
Table 26. Global Cardiovascular Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Cardiovascular Therapy Revenue Market Share by Type (2026-2031)
Table 28. Global Cardiovascular Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Cardiovascular Therapy Revenue Market Share by Application (2020-2025)
Table 30. Global Cardiovascular Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Cardiovascular Therapy Revenue Market Share by Application (2026-2031)
Table 32. North America Cardiovascular Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Cardiovascular Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Cardiovascular Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Cardiovascular Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Cardiovascular Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Cardiovascular Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Cardiovascular Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Cardiovascular Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Cardiovascular Therapy Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Cardiovascular Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Cardiovascular Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Cardiovascular Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Cardiovascular Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Cardiovascular Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Cardiovascular Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 47. Medtronic Company Details
Table 48. Medtronic Business Overview
Table 49. Medtronic Cardiovascular Therapy Product
Table 50. Medtronic Revenue in Cardiovascular Therapy Business (2020-2025) & (US$ Million)
Table 51. Medtronic Recent Development
Table 52. Boston Scientific Company Details
Table 53. Boston Scientific Business Overview
Table 54. Boston Scientific Cardiovascular Therapy Product
Table 55. Boston Scientific Revenue in Cardiovascular Therapy Business (2020-2025) & (US$ Million)
Table 56. Boston Scientific Recent Development
Table 57. Abbott Company Details
Table 58. Abbott Business Overview
Table 59. Abbott Cardiovascular Therapy Product
Table 60. Abbott Revenue in Cardiovascular Therapy Business (2020-2025) & (US$ Million)
Table 61. Abbott Recent Development
Table 62. LivaNova Company Details
Table 63. LivaNova Business Overview
Table 64. LivaNova Cardiovascular Therapy Product
Table 65. LivaNova Revenue in Cardiovascular Therapy Business (2020-2025) & (US$ Million)
Table 66. LivaNova Recent Development
Table 67. BIOTRONIK Company Details
Table 68. BIOTRONIK Business Overview
Table 69. BIOTRONIK Cardiovascular Therapy Product
Table 70. BIOTRONIK Revenue in Cardiovascular Therapy Business (2020-2025) & (US$ Million)
Table 71. BIOTRONIK Recent Development
Table 72. Research Programs/Design for This Report
Table 73. Key Data Information from Secondary Sources
Table 74. Key Data Information from Primary Sources
Table 75. Authors List of This Report


List of Figures
Figure 1. Cardiovascular Therapy Picture
Figure 2. Global Cardiovascular Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Cardiovascular Therapy Market Share by Type: 2024 VS 2031
Figure 4. Diabetes Features
Figure 5. Obesity Features
Figure 6. Others Features
Figure 7. Global Cardiovascular Therapy Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Cardiovascular Therapy Market Share by Application: 2024 VS 2031
Figure 9. Hospital Case Studies
Figure 10. Clinic Case Studies
Figure 11. Cardiovascular Therapy Report Years Considered
Figure 12. Global Cardiovascular Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Cardiovascular Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Cardiovascular Therapy Market Share by Region: 2024 VS 2031
Figure 15. Global Cardiovascular Therapy Market Share by Players in 2024
Figure 16. Global Top Cardiovascular Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cardiovascular Therapy as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Cardiovascular Therapy Revenue in 2024
Figure 18. North America Cardiovascular Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Cardiovascular Therapy Market Share by Country (2020-2031)
Figure 20. United States Cardiovascular Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Cardiovascular Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Cardiovascular Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Cardiovascular Therapy Market Share by Country (2020-2031)
Figure 24. Germany Cardiovascular Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Cardiovascular Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Cardiovascular Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Cardiovascular Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Cardiovascular Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Cardiovascular Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Cardiovascular Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Cardiovascular Therapy Market Share by Region (2020-2031)
Figure 32. China Cardiovascular Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Cardiovascular Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Cardiovascular Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Cardiovascular Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Cardiovascular Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Cardiovascular Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Cardiovascular Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Cardiovascular Therapy Market Share by Country (2020-2031)
Figure 40. Mexico Cardiovascular Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Cardiovascular Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Cardiovascular Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Cardiovascular Therapy Market Share by Country (2020-2031)
Figure 44. Turkey Cardiovascular Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Cardiovascular Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Cardiovascular Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Medtronic Revenue Growth Rate in Cardiovascular Therapy Business (2020-2025)
Figure 48. Boston Scientific Revenue Growth Rate in Cardiovascular Therapy Business (2020-2025)
Figure 49. Abbott Revenue Growth Rate in Cardiovascular Therapy Business (2020-2025)
Figure 50. LivaNova Revenue Growth Rate in Cardiovascular Therapy Business (2020-2025)
Figure 51. BIOTRONIK Revenue Growth Rate in Cardiovascular Therapy Business (2020-2025)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies